the Company announced that its Board appointed Stephanie Hogue, the Company’s President, as Chief Executive Officer effective as of the Effective Date.
On June 17, 2025, Mike Dickerson, the Chief Financial Officer of Twin Vee PowerCats Co. (the “Company”), notified the Company of his decision to resign, effective September 14, 2025, from his position as the Company’s Chief Financial Officer.
the Board of Directors appointed Lawrence Garcia, a director of the Board and Board Chairman as Chief Executive Officer of the Company to assume such executive responsibilities, effective immediately.
the Board of Directors of AmeriGuard Security Services, Inc., removed Douglas Anderson, from the position of Interim Chief Executive Officer of the Company, effective immediately.
On June 18, 2025, Ciena Corporation (the “Company”) announced the appointment of Marc D. Graff as Senior Vice President and Chief Financial Officer and that the Board of Directors of the Company (the “Board”) has designated Mr. Graff as the Company’s principal financial officer and principal accounting officer, effective, in each case, as of August 1, 2025 (the “Effective Date”).
The Board of Directors (the “Board”) of Climb Bio, Inc. (the “Company”) appointed Cindy Driscoll as Senior Vice President, Finance of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective as of June 17, 2025
In connection with Hugues Meyrath’s appointment as President and Chief Executive Officer of Quantum Corporation (the “Company”), on June 12, 2025, Mr. Meyrath entered into an offer letter (the “Offer Letter”) with the Company providing for the following terms:
Jeremy Garber, the Company’s President, Treasurer and Secretary was appointed to serve as the Company’s interim Chief Financial Officer while the Company conducts a search process for a permanent successor effective on the Transition Date.
Robert B. Klein announced his intention to resign from his role as Chief Financial Officer of Postal Realty Trust, Inc. (the “Company”) in order to accept a position with a privately-held real estate company.
the Board of Directors (the “Board”) of Amaze Holdings, Inc. (the “Company) appointed Aaron Day as Chief Executive Officer and Chairman of the Board of the Company.
elected Christopher Turner, currently Chief Financial and Franchise Officer of the Company, as Chief Executive Officer of the Company, effective October 1, 2025
David Gibbs, who, in March 2025, informed the Board of Directors of his intention to retire in the next year after 37 years with the Company and a successful tenure as CEO.
On June 17, 2025, the Board elected Judith Murrah, the Company’s current President, as Chief Executive Officer and as Chairperson and a member of the Board effective June 18, 2025.
Departed
Dr. James A. Hayward
Chief Executive Officer, Chairman of the Board and Director
On June 16, 2025, Dr. James A. Hayward informed Applied DNA Sciences, Inc. (the “Company”) of his intention to retire from the Company and that he will step down from his positions as Chief Executive Officer, member of the Company’s board of directors (the “Board”) and Chairman of the Board effective June 18, 2025.
On June 17, 2025, Hamilton Insurance Group, Ltd. (the “Company”) announced that Megan Graves, Chief Executive Officer (“CEO”) of Hamilton Re, Ltd. (“Hamilton Re”) and a named executive officer of the Company, notified the Company of her decision to step down from her role as CEO of Hamilton Re, effective September 1, 2025.
Appointed
Alex Baker
Chief Executive Officer of Hamilton Global Specialty
The Company also announced that Alex Baker, currently the Company’s Group Chief Risk Officer, has been appointed to succeed Mr. Daws as Chief Executive Officer of Hamilton Global Specialty, subject to regulatory approval, and with effect from September 1, 2025.
the Company also announced that Adrian Daws, currently the Chief Executive Officer of Hamilton Global Specialty and a named executive officer of the Company, has been appointed to serve as CEO of Hamilton Re with effect from September 1, 2025, subject to regulatory and Bermuda immigration approval.
On June 11, 2025, Paul Joachimczyk, Senior Vice President and Chief Financial Officer of American Woodmark Corporation (the “Company”), provided his resignation from the Company, effective June 27, 2025, as he is taking the principal financial officer role at another public company.
Appointed
(interim)
M. Scott Culbreth
interim principal financial officer and interim principal accounting officer
Upon the effectiveness of Mr. Joachimczyk’s resignation, M. Scott Culbreth, the Company’s current President and Chief Executive Officer, will also become the Company’s interim principal financial officer and interim principal accounting officer.
On June 12, 2025, Onto Innovation Inc. (the “Company”) announced that Brian Roberts has been appointed as the Company’s Chief Financial Officer (“CFO”) effective as of June 16, 2025 (the “Hire Date”) .
Appointed
(interim)
Sean Fukumura
Interim Chief Financial Officer, Treasurer, and Secretary
terminated Randall Starr as Co-Chief Executive Officer, Co-President, Chief Financial Officer, Treasurer and Secretary of the Company for cause, effective immediately.
Departed
Gillian Munson
Chief Financial Officer
Vimeo, Inc.
Effective
2025-08-08
Filed
June 16, 2025, 7:59 PM ET
On June 16, 2025, Vimeo, Inc. (“Vimeo” or the “Company”) announced that Gillian Munson will step down as the Company’s Chief Financial Officer, effective August 8, 2025 (the “Separation Date”).
On June 16, 2025, SmartRent, Inc. (the “Company”) announced the appointment of Frank Martell as President and Chief Executive Officer of the Company, effective as of Mr. Martell’s employment start date of June 16, 2025
On June 12, 2025, Expro Group Holdings N.V. (the “Company”) announced the appointment by the board of directors (the “Board”) of Sergio Maiworm to serve as Chief Financial Officer, succeeding Quinn Fanning, effective June 30, 2025 (the “Effective Date”).
Craig J. Demarest will retire as the Chief Financial Officer and principal financial and accounting officer of Crown Crafts, Inc. (the “Company”), effective June 30, 2025.
Appointed
Claire K. Spencer
Chief Financial Officer, Secretary and principal financial and accounting officer
On June 16, 2025, the Company’s Board of Directors appointed Claire K. Spencer as the Company’s: (i) Vice President, effective June 16, 2025; and (ii) Chief Financial Officer, Secretary and principal financial and accounting officer, effective June 30, 2025 upon Mr. Demarest’s retirement as the Company’s Chief Financial Officer and principal financial and accounting officer.
Departed
Kristofer Heaton
Vice President of Finance and Principal Financial Officer
Kristofer Heaton resigned from the positions of Vice President of Finance and Principal Financial Officer of United Health Products effective on June 12, 2025, citing consideration of personal and professional factors.
On June 14, 2025, the Company appointed Charles (“Kip”) Compton, the Company’s current Chief Product Officer, to serve as the Company’s Chief Executive Officer and as a Class I member of the Board with a term expiring at the Company’s 2026 annual meeting of stockholders, effective as of the Effective Date.
On June 13, 2025, Todd Nightingale, Chief Executive Officer of Fastly, Inc. (the “Company”), notified the Company of his resignation as Chief Executive Officer and President to pursue another opportunity.
On June 11, 2025, the Board of Directors (the “Board”) of Athene Holding Ltd. (the “Company”) appointed Grant Kvalheim, the Company’s current President, as the Company’s Chief Executive Officer, effective July 1, 2025.
On June 10, 2025, Don Kim, Chief Financial Officer of Tharimmune, Inc. (the “Company”) resigned from his position as CFO for personal reasons, effective immediately.
On June 13, 2025, upon the recommendation and approval of the audit committee and compensation committee, the Board appointed Vikas Mittal as new Chief Financial Officer of the Company, effective immediately.
On June 13, 2025, Harry L. You notified the board of directors (the “Board”) of his resignation as Interim Chief Financial Officer of the Company, effective immediately.
Effective June 15, 2025, the Board of Directors of the Company appointed Mr. John P. Larson as President and Chief Executive Officer of the Company on a permanent basis, following his interim appointment in February 2025.
On June 10, 2025, Jean-Marc Bellemin, the Chief Financial Officer and principal financial and accounting officer of Iovance Biotherapeutics, Inc. (the “Company”), provided the Company with written notice under his Executive Employment Agreement, dated November 23, 2020, that he would resign from the Company, effective July 10, 2025, to pursue other opportunities.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.